Bibliography
- Malow BA. Approach to the patient with disordered sleep. In: Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement WC, editors. Philadelphia: Elsevier Saunders; 2005. p. 590-1
- Roehrs T, Carskdon MA, Dement WC, Roth T. Daytime sleepiness and alertness. In: Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement WC, editors. Philadelphia: Elsevier Saunders; 2005. p. 47-8
- American Academy of Sleep Medicine. International Classification of Sleep Disorders. 2nd edition. Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine; 2005
- Naumann A, Daum I. Narcolepsy: pathophysiology and neuropsycological changes. Behav Neurol 2003;14:89-98
- Daniels L. Narcolepsy. Medicine (Baltimore) 1934;13:1-122
- Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998;50:S16-22
- Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine–Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003;74:1667-73
- Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;51:660
- Mignot E. Pathophysiology of narcolepsy. In: Principles and Practice of Sleep Medicine. 3rd edition. Kryger M, Roth T, Dement W, editors. Philadelphia: Saunders; 2000. p. 663-75
- Mignot E, Hayduk R, Black J, et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20:1012-20
- Nishino S, Ripley B, Overeem S, et al. Hypocretin (Orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40
- Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004;291:2013-6
- Kales A, Cadieux RJ, Bixler EO, et al. Severe obstructive sleep apnea. I: onset, clinical course, and characteristics. J Chron Dis 1985;38:419-25
- Greenberg GD, Watson RK, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987;10:254-62
- US Department of Health and Human Services, National Institutes of Health. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Washington, DC: National Institutes of Health; 2003
- Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet 1985;2:1325-6
- Shepard JJ. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992;13:437-58
- Hack M, Davies RJ, Mullins R, et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnea. Thorax 2000;55:224-31
- Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30:711-9
- Akerstedt T. Adjustment of physiological circadian rhythms and the sleep wake cycle to shift work. In: Hours of Work: Temporal Factors in Work Scheduling. Folkard S, Monk TH, editors. New York: John Wiley & Sons; 1985. p. 185-98
- Nuvigil™ (armodafinil) tablets. Prescribing information. Available from: http://www.cephalon.com/newsroom/assets/nuvigil_prescribing_information.pdf [Last accessed 27 February 2008]
- Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 2003;42:123-37
- Wong YN, King SP, Simcoe D, et al. Open label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol 1999;39:281-8
- Wong YN, Simcoe D, Harman LN, et al. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 1999;39:30-40
- Boyd B, Castaner J. Armodafinil. Drugs Future 2006;31:17-21
- Dinges DF, Arora S, Darwish M, Niebler GE. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Curr Med Res Opin 2006;22:159-67
- Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8
- Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 1996;93:14128-33
- Nishino S, Mignot E. Wake-promoting medications: basic mechanisms and pharmacology. In: Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement WC, editors. Philadelphia: Elsevier Saunders; 2005. p. 476-8
- Wisor JP, Dement WC, Aimone L, et al. Armodafinil, the r-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat. Pharmacol Biochem Behav 2006;85:492-9
- Harsh JR, Haydak R, Rosenberg R, et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin 2006;22:761-74
- Roth T, White D, Schmidt-Nowara W, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 2006;28:689-706
- Hirshkowitz M, Black JE, WesnesK, et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 2007;101:616-27
- Hull S, Lankford A, Vince B, et al. Armodafinil improves fatigue in patients with excessive sleepiness due to obstructive sleep apnea/hypopnea syndrome. American Psychiatric Association Annual Meeting; May 25; Toronto, Canada; 2006
- Drake C, Walsh J, Roth T. Armodafinil improves sleep latency in patients with shift work sleep disorder [abstract]. Sleep 2006;29(Suppl):A64
- Cephalon, Inc. Acetamid derivative having defined particle size. USRE37516 (2002)
- Cephalon, Inc. Levorotatory isomer of benzhydrylsulfinyl derivatives. US4927855 (1990)
- Schwartz JR, Nelson MT, Schwartz ER, et al. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness. Clin Neuropharmacol 2004;27:74-9